TNF and neoplasm: Certain tumor-derived miRNAs, including miR-3187-3p, miR-498, miR-122, miR149, and miR-181a/b, diminished T-cell receptor signaling strength and inhibited the production of TNFa, a key effector molecule in anti-tumor immunity (240).